Sonoma Pharmaceuticals, Inc.
corporate_fare Company Profile
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 19 items for SNOA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 8/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for SNOA spans 10-Q, DEFA14A, 424B5, 10-K.
Recent high-impact activity:
- Sonoma Pharma Q1 Revenue Jumps 60% to $6.4M, Nears Breakeven
- Sonoma Nears Breakeven as Revenue Jumps 60%, But Nasdaq Delisting Risk Looms
- Sonoma Pharmaceuticals Adjourns Special Meeting to July 22, Citing Lack of Quorum for Nevada Reincorporation Vote
- Sonoma Pharma Expands ATM Offering to $3.64M, Over 60% of Market Cap
- Sonoma Pharmaceuticals Expands ATM Program to $3.6M, Reports $574K in Recent Stock Sales
Financial Snapshot
Short Interest & Short Volume
4.45 days to coverFINRA reported short interest of 201,492 shares in SNOA as of the September 15, 2026 settlement, a 10.5% increase from the prior period — about 4.5 days to cover at its recent average daily volume. On October 2, 2026, 52.9% of SNOA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for SNOA, detected from its recent SEC filings · based on capital-structure filings through 2026-06-18.
ATM Program Expansion · Recent Stock Sales Reported
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →